Responses
Oral
Small bowel & nutrition free papers
OC-082 26-Week efficacy and safety of once-daily oral linaclotide in patients with irritable bowel syndrome with constipation (IBS-C): a European perspective
Compose a Response to This Article
Other responses
No responses have been published for this article.